Dynemicin C antitumor antibiotic
    4.
    发明公开
    Dynemicin C antitumor antibiotic 失效
    抗肿瘤药物抗生素

    公开(公告)号:EP0484856A2

    公开(公告)日:1992-05-13

    申请号:EP91118770.6

    申请日:1991-11-04

    CPC分类号: C07D491/04 C12P17/18 C12R1/29

    摘要: The novel antitumor antibiotic of formula (I) designated herein as dynemicin C is produced by fermentation of Micromonospora chersina M956-1 mutant F1085 (ATCC-55077). Dynemicin C and its triacetate derivative possess antibacterial and antifungal activity and also inhibit the growth of mammalian tumors.

    摘要翻译: 本文命名为Dynemicin C的式(I)抗新药抗生素由Micromonospora chersina M956-1突变体F1085(ATCC-55077)的发酵产生。 Dynemicin C及其三醋酸酯衍生物具有抗菌和抗真菌活性,也抑制哺乳动物肿瘤的生长。

    N-acyl derivatives of the LL-E33288 antitumor antibiotics
    5.
    发明公开
    N-acyl derivatives of the LL-E33288 antitumor antibiotics 失效
    N-Acylderivate der Antitumor-Antibiotika vom Typ LL-E33288。

    公开(公告)号:EP0392376A2

    公开(公告)日:1990-10-17

    申请号:EP90106601.9

    申请日:1990-04-06

    IPC分类号: C07H15/203 A61K31/70

    CPC分类号: C07H15/203 C12P19/60 C12R1/29

    摘要: The invention is N-acyl and dihydro-N-acyl analogs of formula (I) of the family of antibacterial and antitumor agents known collectively as the E33288 complex.
    wherein W is
    R is hydrogen or a branched or unbranched alkyl (C₁-C₁₀) or alkylene (C₁-C₁₀) group, an aryl or hetero-aryl group, or an aryl-alkyl (C₁-C₅) or hetero-aryl-alkyl (C₁-C₅) group, all optionally substituted by one or more hydroxy, amino, carboxy, halo, nitro, lower (C₁-C₃) alkoxy, or lower (C₁-C₅) thioalkoxy groups; R₁ is H or
    R₂ is CH₃, C₂H₅ or CH(CH₃)₂; R₄ is OH when R₅ is H or R₄ and R₅ taken together are a carbonyl; and X is an iodine or bromine atom.

    摘要翻译: 本发明是共同称为E33288络合物的抗菌和抗肿瘤剂家族的式(I)的N-酰基和二氢-N-酰基类似物。 其中W是 R是氢或支链或非支链烷基(C1-C10)或亚烷基(C1-C10)基团,芳基或杂芳基或芳基 - 烷基(C1-C5) 或任选被一个或多个羟基,氨基,羧基,卤素,硝基,低级(C 1 -C 3)烷氧基或低级(C 1 -C 5)硫代烷氧基取代的杂芳基 - 烷基(C 1 -C 5) R1是H或CHEM,R2是CH3,C2H5或CH(CH3)2; 当R 5为H或R 4时,R 4为OH,R 5一起为羰基; X是碘或溴原子。